Janusz Rak Selected Research

Factor VII (Proconvertin)

12/2017	Inhibition of tissue factor signaling in breast tumour xenografts induces widespread changes in the microRNA expression profile.
4/2010	Role of the tissue factor pathway in the biology of tumor initiating cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Janusz Rak Research Topics

Disease

89	Neoplasms (Cancer) 02/2023 - 04/2002
12	Glioma (Gliomas) 11/2023 - 05/2008
12	Thrombosis (Thrombus) 01/2023 - 07/2002
11	Glioblastoma (Glioblastoma Multiforme) 01/2024 - 08/2010
10	Hypoxia (Hypoxemia) 01/2022 - 10/2003
10	Neoplasm Metastasis (Metastasis) 01/2021 - 02/2004
9	Brain Neoplasms (Brain Tumor) 12/2019 - 01/2012
4	Inflammation (Inflammations) 04/2016 - 11/2006
3	Breast Neoplasms (Breast Cancer) 01/2022 - 12/2017
3	Disease Progression 02/2016 - 04/2004
3	Lewis Lung Carcinoma 09/2014 - 10/2003
3	Fibrosarcoma 10/2005 - 08/2003
2	Hemorrhage 01/2023 - 07/2002
2	Infections 10/2022 - 01/2020
2	Prostatic Neoplasms (Prostate Cancer) 04/2022 - 12/2017
2	Photosensitivity Disorders (Photodermatitis) 02/2019 - 07/2015
2	Medulloblastoma 02/2016 - 01/2012
2	Atherosclerosis 09/2014 - 10/2007
2	Colorectal Neoplasms (Colorectal Cancer) 11/2013 - 02/2013
2	Tics (Tic) 04/2012 - 12/2009
2	Thrombophilia 03/2009 - 02/2006
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 02/2004 - 10/2002
1	COVID-19 12/2024
1	Virus Diseases (Viral Diseases) 10/2022
1	Venous Thromboembolism 01/2022
1	Rhabdoid Tumor (Rhabdoid Tumors) 01/2020
1	Aneuploidy (Aneuploid) 01/2020
1	Small Cell Carcinoma 01/2019

Drug/Important Bio-Agent (IBA)

30	Thromboplastin (Tissue Factor)IBA 01/2024 - 02/2004
21	Proteins (Proteins, Gene)FDA Link 10/2022 - 10/2005
16	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2012
16	ErbB Receptors (EGF Receptor)IBA 06/2019 - 10/2002
12	epidermal growth factor receptor VIIIIBA 11/2023 - 05/2008
11	Biomarkers (Surrogate Marker)IBA 02/2023 - 03/2009
7	CoagulantsIBA 01/2023 - 10/2014
7	Hemostatics (Antihemorrhagics)IBA 01/2022 - 02/2004
6	AnticoagulantsIBA 01/2023 - 07/2002
6	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2020 - 04/2004
6	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2013 - 04/2002
5	Oncogene Proteins (Oncogene Protein)IBA 02/2023 - 11/2010
5	MicroRNAs (MicroRNA)IBA 12/2018 - 01/2012
5	Thrombospondin 1IBA 04/2013 - 08/2003
4	Temozolomide (Temodar)FDA LinkGeneric 01/2022 - 01/2018
4	Messenger RNA (mRNA)IBA 12/2017 - 10/2002
3	ChromatinIBA 01/2022 - 01/2019
3	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 06/2005
3	RNA (Ribonucleic Acid)IBA 01/2021 - 08/2016
3	Cyclin D1IBA 01/2020 - 01/2019
3	ProteomeIBA 01/2020 - 10/2013
3	LipidsIBA 01/2017 - 05/2008
3	Angiogenesis InhibitorsIBA 10/2005 - 10/2003
2	Nucleic AcidsIBA 02/2023 - 01/2017
2	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2023 - 06/2019
2	Blood Coagulation Factors (Coagulation Factor)IBA 06/2019 - 01/2019
2	Heparin (Liquaemin)FDA LinkGeneric 12/2017 - 07/2002
2	Factor VII (Proconvertin)IBA 12/2017 - 04/2010
2	Monoclonal AntibodiesIBA 12/2017 - 02/2004
2	Trastuzumab (Herceptin)FDA Link 12/2017 - 07/2010
2	FibrinIBA 02/2016 - 12/2009
2	Canertinib (CI 1033)IBA 10/2015 - 07/2010
2	tyrosine receptor (receptor, tyrosine)IBA 10/2015 - 07/2010
2	Phosphotransferases (Kinase)IBA 10/2015 - 07/2010
2	Cetuximab (Erbitux)FDA Link 10/2015 - 02/2004
2	Apolipoproteins E (ApoE)IBA 09/2014 - 10/2007
2	Peptide Hydrolases (Proteases)FDA Link 01/2013 - 12/2009
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2008 - 10/2007
2	Antimitotic AgentsIBA 10/2007 - 10/2002
1	maleimideIBA 12/2024
1	SARS-CoV-2 3C-like proteinaseIBA 12/2024
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2023
1	Factor XI (Plasma Thromboplastin Antecedent)IBA 01/2023
1	AngiotensinsIBA 10/2022
1	Viral ProteinsIBA 10/2022
1	5-thiocyanato-2'-deoxyuridineIBA 04/2022
1	NucleosidesIBA 01/2022
1	Oxygen (Dioxygen)IBA 01/2022
1	Radiation-Sensitizing AgentsIBA 01/2022
1	Bromodeoxyuridine (BrdU)IBA 01/2022
1	Histones (Histone)IBA 01/2022
1	Steryl-Sulfatase (Steroid Sulfatase)IBA 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	Histone Deacetylase InhibitorsIBA 01/2021
1	fibrin fragment D (D-dimer)IBA 01/2021
1	ethylisopropylamiloride (EIPA)IBA 01/2021
1	Platelet Factor 4IBA 01/2021
1	CalciumIBA 01/2021
1	CytokinesIBA 12/2020
1	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2020
1	Matrix Metalloproteinases (MMPs)IBA 09/2020
1	EnzymesIBA 09/2020
1	Phosphates (Orthophosphate)IBA 01/2020
1	CytosineIBA 01/2020
1	GuanineIBA 01/2020
1	ZR2002IBA 12/2019
1	Bromouracil (5 Bromouracil)IBA 02/2019
1	IntegrinsIBA 01/2019

Therapy/Procedure

23	Therapeutics 02/2023 - 02/2004
7	Drug Therapy (Chemotherapy) 01/2023 - 04/2002
4	Radiotherapy 01/2022 - 12/2017
2	Photochemotherapy (Photodynamic Therapy) 02/2019 - 07/2015